Goodpath, a Cambridge, Ma.-based telehealth startup focused on helping people managing common health conditions, raised $4m in seed funding.
The round was led by GFC, with participation from Indicators Ventures, Switch Ventures and Blindspot Ventures.
The company intends to use the funds to continue to expand operations and its business reach.
Co-founded by CEO Bill Gianoukos, Carl Nehme (COO & CPO), and Dr. Akl Fahed (Chief Medical Advisor), Goodpath is a provider of a telehealth platform offering personalized care programs for sleep, back pain and Irritable Bowel Syndrome.
A Goodpath program is an integrative set of treatments personalized just for every patient. Programs can include nutrition and supplements (such as nutrition coaching and targeted supplements); movement and lifestyle (like online yoga or strengthening exercises); mindfulness and meditation (like guided meditations and journaling), and coaching and guidance (1:1 coaching and other guidance to help people reach their goals).